U.S. Senate Democrats advance deal to lower drug prices [Reuters]
Bristol-Myers Squibb Company (BMY)
Last bristol-myers squibb company earnings: 2/6 07:05 am
Check Earnings Report
US:NYSE Investor Relations:
bms.com/investors.html
Company Research
Source: Reuters
and disabled Americans to negotiate lower prescription drug prices, Senate sources said on Wednesday. The plan, which could potentially lower government health costs by billions of dollars, has long been a goal of President Joe Biden's Democrats and is popular with voters. Affected drugs could include Bristol-Myers Squibb Co's (BMY.N) top-selling cancer drug Revlimid, AbbVie Inc's (ABBV.N) rheumatoid arthritis drug Humira, and Bayer AG's (BAYGn.DE) blood thinner pill Xarelto, according to the Kaiser Family Foundation (KFF). Advertisement · Scroll to continue The plan has been held up by contentious intra-party negotiations on taxes, climate change and other elements of a proposed domestic policy bill. The sources said all 50 Senate Democrats support the drug plan, including Senator Joe Manchin, who is often at odds with other members of his party. "His support for this proposal has never been in question," Manchin spokesperson Sam Runyon said in a statement. Advertisemen
Show less
Read more
Impact Snapshot
Event Time:
BMY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
BMY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
BMY alerts
High impacting Bristol-Myers Squibb Company news events
Weekly update
A roundup of the hottest topics
BMY
News
- 2seventy bio, Inc. (NASDAQ:TSVT) Q1 2024 Earnings Call Transcript [Yahoo! Finance]Yahoo! Finance
- Qihan Biotech Appoints Yingyong Xu as its Chief Medical Officer [Yahoo! Finance]Yahoo! Finance
- Bristol-Myers Squibb Insiders Sell US$1.1m Of Stock, Possibly Signalling Caution [Yahoo! Finance]Yahoo! Finance
- Klick Health Wraps First Round of $1,000,000 Klick AI Prize, Awarding First $200,000 to Three Teams [Yahoo! Finance]Yahoo! Finance
- Bristol Myers Squibb to Participate in Upcoming Investor ConferencesBusiness Wire
BMY
Earnings
- 4/25/24 - Miss
BMY
Sec Filings
- 5/9/24 - Form 8-K
- 5/3/24 - Form 4
- 4/25/24 - Form 10-Q
- BMY's page on the SEC website